e-CBT DTx for Post Traumatic Headaches in Adults With History of TBI

NCT ID: NCT06669780

Last Updated: 2025-09-19

Basic Information

• Recruitment Status: ACTIVE_NOT_RECRUITING
• Clinical Phase: NA
• Total Enrollment: 100 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-01-03
• Study Completion Date: 2026-06-30

Brief Summary

The AMMO digital therapeutic (DTx) study will provide an online based program for participants with migraines after head injury to follow for 12 weeks. This study aims to see if using cognitive behavioral therapy aimed at military service members in an online self administered platform is effective therapy in the relief of migraines compared. The study will use a single blind online comparative program to test the effect.

Detailed Description

The AMMO digital therapeutic (DTx) will be a novel intervention for PTH following concussive TBI, therefore this project is a pilot trial designed to test this new treatment. This pilot is a single-blind, randomized, controlled, interventional trial of current and former military personnel along with civilians with a history of concussive TBI and current PTH. The pilot trial will be conducted via online portal accessible by smartphone, tablet, or computer with remote interaction between participants and study staff. The pilot trial will include up to 100 participants randomized to either the active intervention or a comparison condition at a 1:1 ratio, and will provide preliminary data to determine the sample size of a future full clinical trial. Participants will complete a 12 week intervention period followed by a follow-up assessment 4 weeks after intervention is complete. Participants randomized to the comparison group will be provided access to the open label after end of 16 week follow-up.

In addition, updates to the DTx to improve usability and acceptability will be made if necessary based on feedback from the pilot trial, then applied to the final DTx used in a future, larger, clinical trial.

Conditions

Post-Traumatic Headache

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: SINGLE

Study Groups

Active

This arm will receive access to an online program that will guide them through cognitive behavioral therapy program.

Group Type: EXPERIMENTAL

AMMO PTH DTx

Intervention Type: DEVICE

An online cognitive behavioral therapy program accessed through a online program.

Sham comparator

Participants will obtain access to an online program with activities not including the cognitive behavioral therapy

Group Type: SHAM_COMPARATOR

AMMO SHAM

Intervention Type: DEVICE

Online activities not including CBT in the AMMO online program.

Interventions

AMMO PTH DTx

An online cognitive behavioral therapy program accessed through a online program.

Intervention Type: DEVICE

AMMO SHAM

Online activities not including CBT in the AMMO online program.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Be aged ≥ 18 to ≤ 70 years
• Have a history of concussive TBI ≥ 3 months prior to enrollment:
• A concussive TBI is defined by having at least one of the following after a head trauma (ACRM, 1993) oAny period of loss of consciousness; oAny loss of memory for events immediately before or after the accident; oAny alteration in mental state at the time of the accident (e.g., feeling dazed, disoriented, or confused); and oFocal neurological deficit(s) that may or may not be transient oThe injury must not exceed any of the following (ACRM, 1993):
• Loss of consciousness of approximately 30 minutes or less;
• After 30 minutes an initial GCS score of 13-15; and
• PTA not greater than 24 hours

• Head trauma resulting in concussive TBI can be due to blast or non-blast mechanisms
• Head trauma resulting in concussive TBI can have occurred any time in the participant's life: prior to military service, during deployment, in garrison, or after leaving military service
• Have a history of chronic PTH defined as:

o Headache is reported to have developed (or worsened) after one of the following*:

• The injury to the head;
• Regaining of consciousness following the injury to the head; or
• Discontinuation of medication(s) impairing ability to sense or report headache following the injury to the head
• Not better accounted for by another ICHD-3 diagnosis**

o The headache persists for >3 months after its onset (ICHD, 2013)

• Have a HIT-6™ score of ≥ 56 to 78 indicative of substantial impact (56-59) or severe impact (60-78) on functioning (Yang, Rendas-Baum, Varon, & Kosinski, 2011)
• Be able to provide written, informed consent in English and follow study-related instructions
• Have ownership of or reliable access to a smartphone with a data plan or internet connecting capabilities
• Be aged ≥ 18 to ≤ 70 years
• Have a history of concussive TBI ≥ 3 months prior to enrollment:
• A concussive TBI is defined by having at least one of the following after a head trauma (ACRM, 1993):

• Any period of loss of consciousness;
• Any loss of memory for events immediately before or after the accident;
• Any alteration in mental state at the time of the accident (e.g., feeling dazed, disoriented, or confused); and
• Focal neurological deficit(s) that may or may not be transient
• The injury must not exceed any of the following (ACRM, 1993):
• Loss of consciousness of approximately 30 minutes or less;
• After 30 minutes an initial GCS score of 13-15; and
• PTA not greater than 24 hours

• Head trauma resulting in concussive TBI can be due to blast or non-blast mechanisms
• Head trauma resulting in concussive TBI can have occurred any time in the participant's life: prior to military service, during deployment, in garrison, or after leaving military service
• Have a history of chronic PTH defined as:

o Headache is reported to have developed (or worsened) after one of the following*:

• The injury to the head;
• Regaining of consciousness following the injury to the head; or
• Discontinuation of medication(s) impairing ability to sense or report headache following the injury to the head
• Not better accounted for by another ICHD-3 diagnosis**

o The headache persists for >3 months after its onset (ICHD, 2013)

• Have a HIT-6™ score of ≥ 56 to 78 indicative of substantial impact (56-59) or severe impact (60-78) on functioning (Yang, Rendas-Baum, Varon, & Kosinski, 2011)
• Be able to provide written, informed consent in English and follow study-related instructions
• Have ownership of or reliable access to a smartphone with a data plan or internet connecting capabilities

Exclusion Criteria

• They experienced a moderate or severe TBI
• Their secondary headache is better accounted for by the ICHD-3 diagnosis of 8.2 medication-overuse headache; must meet diagnostic criteria for at least 1 medication-overuse headache diagnosis (8.2.1-8.2.8)
• They are currently engaged in psychotherapeutic treatment or have engaged in psychotherapeutic treatment within 8 weeks prior to trial enrollment (for more information regarding recent treatment in potential participants, see section '3.2 Study Procedures,' sub-section 'Baseline Evaluation')
• They report change or discontinuation of headache prophylaxis in the past 4 weeks
• They report active psychotic or bipolar symptoms
• In the opinion of the investigator, they have other considerations that may adversely affect patient safety, participation, or scientific validity of the data being collected (including, but not limited to, active plan or intent for suicide, visual impairment, hand dysfunction or amputation, substantial cognitive impairment, life expectancy of less than 6 months)

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 70 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Uniformed Services University of the Health Sciences

FED

Sponsor Role: collaborator

Henry M. Jackson Foundation for the Advancement of Military Medicine

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Locations

100% Remote Recruitment: Center for Neurscience and Regenerative Medicine

Bethesda, Maryland, United States

Countries

United States

References

Berry K, Salter A, Morris R, James S, Bucci S. Assessing Therapeutic Alliance in the Context of mHealth Interventions for Mental Health Problems: Development of the Mobile Agnew Relationship Measure (mARM) Questionnaire. J Med Internet Res. 2018 Apr 19;20(4):e90. doi: 10.2196/jmir.8252.

Reference Type: BACKGROUND

PMID: 29674307 (View on PubMed)

Stoyanov SR, Hides L, Kavanagh DJ, Wilson H. Development and Validation of the User Version of the Mobile Application Rating Scale (uMARS). JMIR Mhealth Uhealth. 2016 Jun 10;4(2):e72. doi: 10.2196/mhealth.5849.

Reference Type: BACKGROUND

PMID: 27287964 (View on PubMed)

Morin CM, Belleville G, Belanger L, Ivers H. The Insomnia Severity Index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011 May 1;34(5):601-8. doi: 10.1093/sleep/34.5.601.

Reference Type: BACKGROUND

PMID: 21532953 (View on PubMed)

Jenkins MM, Colvonen PJ, Norman SB, Afari N, Allard CB, Drummond SP. Prevalence and Mental Health Correlates of Insomnia in First-Encounter Veterans with and without Military Sexual Trauma. Sleep. 2015 Oct 1;38(10):1547-54. doi: 10.5665/sleep.5044.

Reference Type: BACKGROUND

PMID: 26085301 (View on PubMed)

Bastien CH, Vallieres A, Morin CM. Validation of the Insomnia Severity Index as an outcome measure for insomnia research. Sleep Med. 2001 Jul;2(4):297-307. doi: 10.1016/s1389-9457(00)00065-4.

Reference Type: BACKGROUND

PMID: 11438246 (View on PubMed)

Tulsky DS, Kisala PA, Victorson D, Carlozzi N, Bushnik T, Sherer M, Choi SW, Heinemann AW, Chiaravalloti N, Sander AM, Englander J, Hanks R, Kolakowsky-Hayner S, Roth E, Gershon R, Rosenthal M, Cella D. TBI-QOL: Development and Calibration of Item Banks to Measure Patient Reported Outcomes Following Traumatic Brain Injury. J Head Trauma Rehabil. 2016 Jan-Feb;31(1):40-51. doi: 10.1097/HTR.0000000000000131.

Reference Type: BACKGROUND

PMID: 25931184 (View on PubMed)

Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001 Sep;16(9):606-13. doi: 10.1046/j.1525-1497.2001.016009606.x.

Reference Type: BACKGROUND

PMID: 11556941 (View on PubMed)

Blevins CA, Weathers FW, Davis MT, Witte TK, Domino JL. The Posttraumatic Stress Disorder Checklist for DSM-5 (PCL-5): Development and Initial Psychometric Evaluation. J Trauma Stress. 2015 Dec;28(6):489-98. doi: 10.1002/jts.22059. Epub 2015 Nov 25.

Reference Type: BACKGROUND

PMID: 26606250 (View on PubMed)

Kosinski M, Bjorner JB, Ware JE Jr, Batenhorst A, Cady RK. The responsiveness of headache impact scales scored using 'classical' and 'modern' psychometric methods: a re-analysis of three clinical trials. Qual Life Res. 2003 Dec;12(8):903-12. doi: 10.1023/a:1026111029376.

Reference Type: BACKGROUND

PMID: 14651411 (View on PubMed)

Bjorner JB, Kosinski M, Ware JE Jr. Using item response theory to calibrate the Headache Impact Test (HIT) to the metric of traditional headache scales. Qual Life Res. 2003 Dec;12(8):981-1002. doi: 10.1023/a:1026123400242.

Reference Type: BACKGROUND

PMID: 14651417 (View on PubMed)

Other Identifiers

AMMO-TBI-2023

Identifier Type: -

Identifier Source: org_study_id